WuXi XDC Cayman Future Growth
Future criteria checks 5/6
WuXi XDC Cayman is forecast to grow earnings and revenue by 27.3% and 25.6% per annum respectively. EPS is expected to grow by 35% per annum. Return on equity is forecast to be 16.8% in 3 years.
Key information
27.3%
Earnings growth rate
35.0%
EPS growth rate
| Life Sciences earnings growth | 25.9% |
| Revenue growth rate | 25.6% |
| Future return on equity | 16.8% |
| Analyst coverage | Good |
| Last updated | 24 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 6,474 | 1,489 | 637 | N/A | 17 |
| 12/31/2025 | 4,744 | 1,054 | 101 | N/A | 17 |
| 12/31/2024 | 3,284 | 765 | -827 | N/A | 17 |
| 6/30/2024 | 2,796 | 595 | N/A | N/A | N/A |
| 3/31/2024 | 2,460 | 439 | N/A | N/A | N/A |
| 12/31/2023 | 2,124 | 284 | -207 | 333 | N/A |
| 9/30/2023 | 1,889 | 259 | -114 | 296 | N/A |
| 6/30/2023 | 1,654 | 235 | -21 | 258 | N/A |
| 3/31/2023 | 1,322 | 195 | 15 | 255 | N/A |
| 12/31/2022 | 990 | 156 | 50 | 252 | N/A |
| 12/31/2021 | 311 | 55 | 8 | 59 | N/A |
| 12/31/2020 | 96 | 26 | -32 | 21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: L74's forecast earnings growth (27.3% per year) is above the savings rate (0.8%).
Earnings vs Market: L74's earnings (27.3% per year) are forecast to grow faster than the German market (20% per year).
High Growth Earnings: L74's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: L74's revenue (25.6% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: L74's revenue (25.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: L74's Return on Equity is forecast to be low in 3 years time (16.8%).